Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Página 1 a partir de 34 resultados
Dopaminergic Dysfunction in Late-Life Depression
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Late Life Depression (LLD) is a prevalent, disabling, and at times lethal condition for which currently available treatments are often ineffective. No prior study has comprehensively examined dopamine-dependent behaviors (i.e., reward processing, cognition, motor function) in LLD, and none has
Neurodegenerative Diseases Registry
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This is a cohort study. It involves baseline, 1st follow up visit and 2nd follow up visit. At baseline visit, all participants will go through a list of assessments and questionnaires and blood taking. Follow-up visit(s) will be scheduled every one to two years, in which the same set of assessments
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The increasing prevalence of dementia is a serious threat to our medical system and our society. About 500,000 Canadians are affected with dementia, and this number will rise to more than 1 million in the next 20 years. Dementia already costs our economy 15 billion dollars per year. While much of
French Validation of a Severity Scale in REM Sleep Behavior Disorder (SEV-TCSP)
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Research involving the human person, non-interventional, category 3
80 patients with RBD of any etiology (eg Idiopathic RBD, RBD associated with Parkinson's Disease, Multiple System Atrophy, Narcolepsy etc.) and their bedpartners (if available) will be include in 5 French centers (Clermont-Ferrand,
Modulation of Gut Microbiota by Rifaximin in PD Patients
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Gut microbiota is the largest microorganisms pool in the human body. The physiological roles of gut microbiota for digestion, metabolism, immune homeostasis, GI-tract infection prevention and anti-inflammation. The very first colonized gut microbiota of infant are from maternal vaginal fluid. Gut
Improving Walking Ability in Parkinson Disease
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Parkinson's disease (PD) is a chronic and progressive movement disorder, mainly due to an altered motor control. Gait impairments are the primary symptoms in patients with PD, with a decreased step length and walking speed, abnormal gait phases distribution, inconstant pace, gait asymmetry and
Treadmill in the Rehabilitation of Parkinsonian Gait
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Gait disorders in Parkinson Disease (PD) are due to dopaminergic nigrostriatal pathways degeneration and represent important components of the disability.
In PD, gait is characterized by a significant reduction of stride length. Inadequate flexion at the ankle and knee, reduction of heel strike,
Safinamide for Multiple System Atrophy (MSA)
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The overall design is a parallel group, placebo controlled, double blind study. The target population are participants diagnosed with possible or probable parkinsonian variant of Multiple System Atrophy who are on stable doses of levodopa.
Trial participation will be up to a maximum duration of 14
Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
A challenge to studying automaticity is that central nervous system circuitry for locomotion cannot be directly assessed in humans so shifts between automaticity and executive control have been inferred with a dual-task paradigm. If gait slows or deteriorates during a concurrent cognitive task, gait
Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Age-related macular degeneration (AMD) is the most common cause of blindness, in individuals over the age of 50, in the developed world. AMD becomes more common as people age, and is more common in lightly pigmented individuals. AMD appears more common in patients with Parkinson's Disease, than in
Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
IPO-001 is a prospective, randomized, 3-period cross-over, open-label multicentre trial comparing intravenous and subcutaneous Infudopa with intestinal Duodopa. The patients will be identified and recruited at neurology clinics at university hospital clinical sites in Sweden, and travel from their
Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This is a Phase 2, single-center, randomized, double-blind, placebo-controlled, parallel-group, 2-arm study in patients with mild to moderate PD. There will be three phases to the study. An initial 12-week screening phase was performed to determine eligibility. After informed consents, early-stage
Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Four subjects with a probable MSA-C diagnosis will be recruited for this study. A probable MSA-C diagnosis will be based on the following criteria:
- Autonomic failure involving urinary incontinence (inability to control the release of urine form the bladder, with erectile dysfunction in males) or
Dose Ranging Study of Carbidopa-levodopa
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Age-related macular degeneration (AMD) is the most common cause of blindness, in individuals over the age of 50, in the developed world. AMD becomes more common as people age, and is more common in lightly pigmented individuals. AMD appears more common in patients with Parkinson's Disease, than in
Carbidopa-levodopa in Neovascular AMD
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Age-related macular degeneration (AMD) is the most common cause of blindness, in individuals over the age of 50, in the developed world. AMD becomes more common as people age, and is more common in lightly pigmented individuals. AMD appears more common in patients with Parkinson's Disease, than in
O mais completo banco de dados de ervas medicinais apoiado pela ciência
- Funciona em 55 idiomas
- Curas herbais apoiadas pela ciência
- Reconhecimento de ervas por imagem
- Mapa GPS interativo - marcar ervas no local (em breve)
- Leia publicações científicas relacionadas à sua pesquisa
- Pesquise ervas medicinais por seus efeitos
- Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes
Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas
